Connect with us

Technology

KITS Eyecare Announces Revised Q1 2025 Guidance, Anticipates Higher Adjusted EBITDA Than Previously Forecasted

Published

on

Company Now Expects Adjusted EBITDA as a Percentage of Revenue between 6% and 8%,
Exceeding the Previous Guidance of 4% to 6%.

VANCOUVER, BC, March 17, 2025 /CNW/ – Kits Eyecare Ltd. (TSX: KITS) (“KITS” or the “Company”), a leading vertically integrated eyecare provider, announces an upward revision to the Company’s Q1 2025 Adjusted EBITDA guidance. The Company now expects Q1 Adjusted EBITDA of approximately 6% to 8%, exceeding the previously guided range of 4% to 6%.

Updated First Quarter 2025 Outlook
For the first quarter of 2025, KITS management has increased their Adjusted EBITDA target range of 6% to 8%, an increase from the initial range of 4% to 6%. Forecasted revenue remains between $46 million to $48 million, representing a 32% to 38% growth rate year-over-year.  See “Forward-Looking Statements” below for important disclosure with respect to expectations and forward-looking information.

Management Commentary
“We are pleased to increase our guidance for Adjusted EBITDA from 4-6% to 6-8%, reflecting the strength of our business model and the continued momentum across our key growth drivers,” said Roger Hardy, CEO and Co-Founder of KITS. “We are seeing significant traction in new glasses customers as our latest collections resonate with first-time buyers and drive repeat purchases among existing customers. Consumption per customer remains strong as customers recognize the quality and value of our offering. As we continue to scale, we remain focused on delivering exceptional value to our customers while driving sustainable, margin-accretive growth for our shareholders.”

This revision aligns with our ongoing strategy to deliver consistent growth and operational excellence while maintaining transparency with our investors.

About KITS
KITS makes eyecare easy. KITS is a leading vertically integrated digital eyecare brand providing eyewear for eyes everywhere. We offer customers access to a vast selection of contact lenses and eyeglasses, including our own exclusive KITS designed products, as well as a robust suite of online vision tools. Our efficient digital platform, backed by our industry-leading manufacturing and designs, removes intermediaries, and enables us to offer great prices and deliver made to order personalized products with incredible care and accuracy. We are creating disruption in the industry by constantly pursuing cutting-edge technologies to enable the best customer experience, including online eyewear fitting tools, and virtual try-on for glasses. We strive to delight our customers with our competitive prices, a convenient digital shopping experience, fast and reliable delivery options, and an unrelenting focus on earning our customers’ lifelong trust. For more information on KITS, visit: www.kits.com.

Forward-Looking Statements
This press release contains forward-looking statements, including statements relating to the execution of our proposed strategy, our operating performance, our expectations and outlook for the first quarter of 2025 and prospects for the business. These forward-looking statements generally can be identified by the use of words such as “intend,” “believe,” “could,” “continue,” “expect,” “estimate,” “forecast,” “may,” “potential,” “project,” “plan,” “would,” “will,” and other words of similar meaning. Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such a statement. Our business is subject to substantial risks and uncertainties. This forward-looking information and other forward-looking information are based on our opinions, estimates and assumptions in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we currently believe are appropriate and reasonable in the circumstances. Despite a careful process to prepare and review the forward-looking information, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. Certain assumptions in respect of the expansion and enhancement of our fulfillment network, including our optical laboratory for glasses and warehouse facilities; the growth of our business and launch of new technologies; premium lens adoptions and smart eyewear expansion; our ability to drive sales growth; our ability to maintain, enhance, and grow within our addressable market; our ability to drive ongoing development and innovation of our exclusive brands and product categories; our ability to continue directly sourcing from third party suppliers and manufacturers; our ability to retain key personnel; our ability to add, maintain and expand production, distribution and fulfillment capabilities; our ability to continue investing in infrastructure to support our growth; our ability to obtain and maintain existing financing on acceptable terms; currency exchange and interest rates; the impact of competition; the changes and trends in our industry or the global economy; and the changes in laws, rules, regulations, and global standards. KITS’ risks and uncertainties are discussed in detail in the company’s Annual Information Form, filed on SEDAR on March 5, 2025. Investors, potential investors, and others should give careful consideration to these risks and uncertainties. We caution investors not to rely on the forward-looking statements contained in this press release when making an investment decision in our securities. The forward-looking statements in this press release speak only as of the date of this release, and we undertake no obligation to update or revise any of these statements, except as required under applicable securities laws. If we do update certain forward-looking information, no inference should be made that we will further update such or other forward-looking information.

SOURCE KITS Eyecare Ltd.

Continue Reading

Technology

Kibow® Biotech Announces Availability of Renadyl® in Canada

Published

on

By

Expansion Brings Clinically Studied Kidney Probiotic to
More People Seeking to Maintain Kidney Health

EXTON, Pa., Nov. 19, 2026 /PRNewswire/ — Kibow Biotech, a leading innovator in probiotic dietary supplements for kidney health, today announced the availability of its flagship product, Renadyl, in Canada, marking another important milestone in the company’s mission to expand access to innovative, science-based kidney health solutions worldwide.

Developed through decades of research into the relationship between gut health and kidney function, Renadyl is a patented, clinically studied probiotic supplement scientifically formulated to help maintain healthy kidney function. Its unique approach focuses on the gut microbiome and its role in managing certain waste compounds that can place additional demands on the kidneys.

“Expanding Renadyl’s availability into Canada represents an exciting step forward in our mission to make innovative kidney health solutions accessible to more people,” said Mike Kane, President of Kibow Biotech. “Since 1997, we have been committed to advancing the science behind the gut-kidney connection and developing products that help people take a more proactive role in maintaining their kidney health. We are pleased to bring Renadyl to Canadians looking for additional ways to support their kidney health.”

Chronic Kidney Disease (CKD) affects millions of people worldwide, creating a growing need for approaches that complement traditional kidney care. Renadyl offers a gut-based approach to kidney support, using specially selected probiotic strains to help metabolize certain waste compounds in the intestinal tract and support healthy kidney function.

“As a kidney health advocate and someone who understands firsthand the challenges of living with Chronic Kidney Disease, I am excited to see Renadyl becoming available to more people around the world,” said James Fabin, founder of Dadvice TV and kidney health advocate. “People living with CKD are always looking for ways to take a more active role in their kidney health. Expanding access to products like Renadyl gives more people the opportunity to explore additional options and have informed conversations with their healthcare providers.”

Renadyl features a proprietary blend of three probiotic strains delivering 45 billion colony-forming units (CFUs) per daily serving. Designed to work within the intestinal environment, these beneficial bacteria help support the body’s natural processes for managing certain waste compounds while promoting a healthier gut environment.

The Canadian introduction builds on Kibow Biotech’s longstanding commitment to scientific research, product innovation, and education about the important relationship between gut health and kidney function.

Renadyl is now available to Canadian consumers at Renadyl.ca, where they can purchase the product and learn more about its benefits and how it works.

About Kibow Biotech, LLC
Founded October 1,1997, in Philadelphia, PA, the company’s primary mission is to offer affordable, readily available, and easily administered nutritional supplements to support kidney health and other healthcare applications. Kibow Biotech’s extensive scientific (R&D) and clinical data from multiple studies and scientific human clinical trials have been published in peer-reviewed scientific/medical journals (kibowbiotech.com/rd). The company’s flagship product, Renadyl, is marketed around the world.

Contact Information:
Michelle Adams
President
PRISM Marketing
614-989-6373
michelle@prismmarketing.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/kibow-biotech-announces-availability-of-renadyl-in-canada-302945880.html

SOURCE Kibow Biotech

Continue Reading

Technology

Aptitude 8 Joins the Claude Partner Network as a Select Services Partner

Published

on

By

The recognition formalizes the Claude work Aptitude 8 has already been delivering for enterprise clients and strengthens its AI services practice.

NEW YORK, Nov. 19, 2026 /PRNewswire-PRWeb/ — Aptitude 8, a go-to-market (GTM) operations firm specializing in AI systems, today announced that it has achieved the Select partner tier in the Claude Partner Network Services Track. The tier places Aptitude 8 among the firms recognized for taking customers from pilot programs to production at scale with Claude, powered by Anthropic.

Aptitude 8’s dedicated team of certified Claude architects incorporates Claude into clients’ GTM systems and aligns the data and process it runs on. The firm is continuing to grow its certified Claude team within its AI services practice.

“AI has become essential to how businesses compete, and the companies seeing success are building it on the right foundation, wherever they’re starting from,” said Rob Guinn, CEO of Aptitude 8. “That takes deep expertise in both Claude and the data it runs on, and that combination is exactly what our team brings. Becoming a Select partner means more companies can tap into that expertise as they put Claude to work across their teams.”

Most AI initiatives stall because the system underneath them was never designed for AI. Claude fits the work Aptitude 8 already does across its clients: GTM system implementation, data architecture, systems integration, CRM engineering and portal development. Aptitude 8 architects Claude as the AI layer of a company’s GTM system and the CRM as its context layer, so Claude works from the customer’s own data and process rather than sitting beside them as a separate tool.

Aptitude 8’s Claude work spans MCP architecture that connects Claude to HubSpot and the rest of a company’s stack, custom Claude skill development, design system builds in Claude Design, and enablement and training, including Claude Code for non-developers. As usage grows, the team also helps clients manage token spend so Claude can scale with the business.

Aptitude 8’s work with Claude is already running in production for clients. For a professional services firm, Aptitude 8 turned scattered Claude usage into standardized skills, scheduled tasks and CRM workflows across sales, marketing and delivery, returning more than 1,000 hours of team capacity a year. Every proposal the firm writes now runs through Claude. For a B2B software company, Aptitude 8 built Claude Design and Claude Code workflows and a codebase agent that cut the engineering time spent triaging support requests by 80%.

To mark the announcement, Aptitude 8 is offering a free consultation; book your call at aptitude8.com/claude-services. Learn more about the Claude Partner Network at claude.com/partners.

About Aptitude 8

Aptitude 8 is a go-to-market (GTM) operations firm that architects the systems behind how businesses market, sell, and serve their customers. Deeply rooted in the HubSpot ecosystem, Aptitude 8 brings vast expertise across GTM technology and AI platforms, including Claude, to connect data, align processes, and build the infrastructure businesses need to operate more efficiently and put AI to work. The firm leads with strategy, challenges assumptions, and designs systems built to scale. Aptitude 8 makes growth operationally sound for its customers.

About the Claude Partner Network

The Claude Partner Network is how Anthropic works with the firms that put Claude into production for customers. The Services Track recognizes partners for building a certified delivery team, delivering Claude use cases for clients, and proving the work through public customer references. Partners advance through Certified, Select, Preferred, and Global Premier tiers.

Media Contact

Emily Wingrove, Aptitude 8, 1 302-428-9465, marketing@aptitude8.com, https://aptitude8.com/

View original content to download multimedia:https://www.prweb.com/releases/aptitude-8-joins-the-claude-partner-network-as-a-select-services-partner-302945796.html

SOURCE Aptitude 8

Continue Reading

Technology

Sedgwick White Paper Shows How to Separate Controllable Auto Claim Severity Drivers from Market Pressure

Published

on

By

Five-step framework and auto claim triage guide help carriers identify where claim-process friction is adding avoidable cost and delay

MEMPHIS, Tenn., Nov. 19, 2026 /PRNewswire/ — Rising auto claims severity can feel unprecedented, but Sedgwick has seen this pattern before. In the white paper, The severity you can control: A five-step framework for action, Sedgwick draws on insight from approximately 1 million auto claims every year and decades of historical claims data. Sedgwick shares what’s driving severity and what tends to happen next. Some severity is driven by market conditions. 

Overall, claim frequency has declined across several physical damage coverages, but pressure on carriers remains. Total losses are becoming more common; bodily injury severity continues to rise, and increasingly technical vehicles are changing what it takes to repair and resolve a claim. 

According to CCC Intelligent Solutions, the average paid bodily injury claim rose 10.3% year over year, and 23.1% of claims were flagged as a total loss, a record high across all loss categories. CCC also reports that advanced driver assistance systems (ADAS), sensors and cameras now trigger calibrations on nearly three in ten repairable estimates. Meanwhile, U.S. consumer price data show auto repair costs rose 60% from 2019 to 2026, nearly double the 32% rise in overall inflation. 

“Carriers don’t need more capabilities for their own sake. They need to know where a practical change will make a measurable difference. This framework gives claims leaders a way to find those opportunities and track whether they’re working,” said Chris Bakes, Managing Director, Auto Solutions at Sedgwick. “We know that some severity lives in the sheet metal and some lives in the claim process. The first can only be managed. The second can be controlled.” 

The white paper also outlines Sedgwick insights for evaluating where operational change can create the most value by applying an interactive framework developed by Sedgwick’s auto solutions experts to assess your operation and prioritize cost-containment opportunities for 2027. 

“Towing and storage is a clear example of how timing affects costs. Our towing and storage solution combines claims expertise and technology across negotiation, payment, vehicle release and transfer, helping claims teams act sooner. The result is an average bill of $1,770 versus a $2,600 industry average, a 32% reduction,” said Tim Szpila, Sr. Vice President Business Development at Sedgwick. 

The white paper also includes an auto claim triage guide that shows how information available at first notice of loss (FNOL), such as damage severity, drivability, airbag deployment and vehicle classification, can inform the likely inspection and handling path. A companion set of self-assessment questions helps carriers capture findings and identify priorities. 

The severity you can control: A five-step framework for action white paper is available at online.

About Sedgwick 
Sedgwick is the world’s leading risk and claims administration partner, helping clients thrive by navigating the unexpected. The company’s expertise, combined with the most advanced AI-enabled technology available, sets the standard for solutions in claims administration, loss adjusting, benefits administration and product recall. With over 33,000 colleagues and 10,000 clients across 80 countries, Sedgwick provides unmatched perspective, caring that counts, and solutions for the rapidly changing and complex risk landscape. Sedgwick’s majority shareholder is The Carlyle Group; Stone Point Capital LLC, Altas Partners, CDPQ, Onex and other management investors are minority shareholders. For more, see sedgwick.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sedgwick-white-paper-shows-how-to-separate-controllable-auto-claim-severity-drivers-from-market-pressure-302945902.html

SOURCE Sedgwick Claims Management Services, Inc.

Continue Reading

Trending